Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of ampelopsin sodium in treating bladder cancer

A kind of staphylophyll and bladder cancer technology, applied in the field of medicine, can solve problems such as not suitable for single use, lack of therapeutic drugs and means, and poor tumor suppression effect

Active Publication Date: 2015-03-11
GUANGDONG TAIHE BIOPHARML
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the tumor suppressor effect of AMP-Na alone in the body is very poor, it is currently considered that for general in vivo tumor treatment, AMP-Na is not suitable as a real tumor suppressor, let alone used alone
[0013] To sum up, at present, for bladder cancer and other urinary system tumors, there is still a lack of satisfactory therapeutic drugs and methods.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of ampelopsin sodium in treating bladder cancer
  • New application of ampelopsin sodium in treating bladder cancer
  • New application of ampelopsin sodium in treating bladder cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077]The Distribution and Urinary Excretion of Staphylocin Sodium in Mice

[0078] The present embodiment uses high-performance liquid chromatography to measure the drug concentration of AMP-Na in serum, urine and tissue after mouse i.v. excretion characteristics.

[0079] ① Preparation of standard curve

[0080] First dissolve the standard (AMP or AMP-Na) in PBS (pH6.0) to prepare a standard solution of known concentration, then mix it with serum, urine, organ tissue (such as liver homogenate), and use the mixed sample Make a standard curve.

[0081] Taking the standard curve of AMP-Na in mouse urine as an example, weigh 0.0231g of AMP-Na preparation (containing AMP-Na 7.2mg), dissolve the drug with 0.125ml of PBS (pH6.0), so that the drug concentration is 57.6mg / ml; take 30 μl of drug and add it to 200 μl NS (normal saline) and mouse blank urine, so that the drug concentration is 7533 μg / ml, then dilute the 57.6 mg / ml drug solution in double or triple order with PBS, ta...

Embodiment 2

[0116] Inhibitory effect of staphylosin sodium on the proliferation of human bladder cancer cells in vitro

[0117] ①Cell lines and drugs

[0118] Human bladder invasive cancer cell line EJ, human bladder transitional epithelial cancer cell line 5637, and human bladder superficial transitional cancer cell line BIU-87 were purchased from the cell bank of Shanghai Institute of Cell Biology, Chinese Academy of Sciences. The cell lines were all derived from human primary bladder cancer.

[0119] AMP-Na freeze-dried agent: 180mg / bottle, batch number: 081031, purity 27.8%; special diluent for AMP-Na freeze-dried agent (0.1mol / L, pH=6.8 phosphate buffer): 5ml / bottle, batch number: 081031 , are provided by Guangdong Tahoe Pharmaceutical Technology Co., Ltd.

[0120] Cisplatin (DDP): 10mg / bottle, batch number: 8030031 DB, produced by Jiangsu Qilu Pharmaceutical Co., Ltd.

[0121] ②Experimental method

[0122] The inhibitory effect of AMP-Na on the proliferation of human bladder can...

Embodiment 3

[0169] Study on the effect of intraperitoneal injection of staphylosin sodium in the treatment of transplanted tumors in mouse bladder and orthotopic transplanted tumors of human bladder cancer in nude mice

[0170] ① Drugs and reagents

[0171] AMP-Na, batch number: 100604, specification: 50mg / bottle (lyophilized), provided by Guangdong Taihe Pharmaceutical Technology Co., Ltd., stored at -20°C, diluted with PBS before use. Carboplatin (CBP) for injection (lyophilized type), 0.1g / bottle, product batch number: 0040031.DA.

[0172] ② Animals and cell lines

[0173] Kunming mice (KM), ♀, body weight: 18-22 g, provided by the Medical Experimental Animal Center of Lanzhou University. Nude mice (BALB / c nu / nu), ♀, 6-7w, provided by Hunan Slack Jingda Experimental Animal Co., Ltd. Human bladder cancer EJ cells were purchased from the Cell Bank of Shanghai Institute of Cell Biology, cultured in RPMI 1640 medium (containing 100 U / mL penicillin and 100 μg / mL streptomycin) containing ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a new application of ampelopsin sodium in treating bladder cancer. Particularly, the invention provides a pharmaceutical composition containing ampelopsin or its pharmaceutically acceptable salts. The medicine is administrated intravenously, can effectively treat cancers of the urinary system, especially bladder cancer.

Description

technical field [0001] The present invention relates to the field of medicaments, and more specifically relates to the use of staphylosin sodium in treating cancers of the urinary system, especially the new application of staphylosin sodium in the treatment of bladder cancer through intravenous administration and the like. Background technique [0002] Malignant tumors are a great threat to human health and life, and they and cardiovascular diseases have become two major difficulties in medicine. Bladder cancer is the most common malignant tumor of the urinary system, and its incidence rate ranks first among malignant tumors of the urinary system. Currently, bladder cancer is the ninth most common cancer in the world. According to pathological types, bladder cancer can be divided into epithelial tissue and non-epithelial tissue tumors, epithelial tissue tumors account for 95%, and 90% of them are transitional epithelial tumors (transient cell carcinoma, TCC). In foreign cou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352
Inventor 范富林梁健仪余剑桥
Owner GUANGDONG TAIHE BIOPHARML
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com